PH24664A - Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds and process of preparation thereof - Google Patents

Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds and process of preparation thereof

Info

Publication number
PH24664A
PH24664A PH36006A PH36006A PH24664A PH 24664 A PH24664 A PH 24664A PH 36006 A PH36006 A PH 36006A PH 36006 A PH36006 A PH 36006A PH 24664 A PH24664 A PH 24664A
Authority
PH
Philippines
Prior art keywords
quinolizin
methano
hexahydro
hydroxy
esters
Prior art date
Application number
PH36006A
Other languages
English (en)
Inventor
Maurice Ward Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Priority to PH39830A priority Critical patent/PH26261A/en
Publication of PH24664A publication Critical patent/PH24664A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH36006A 1986-11-03 1987-10-30 Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds and process of preparation thereof PH24664A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH39830A PH26261A (en) 1986-11-03 1990-01-02 Endo-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92661986A 1986-11-03 1986-11-03

Publications (1)

Publication Number Publication Date
PH24664A true PH24664A (en) 1990-09-07

Family

ID=25453460

Family Applications (2)

Application Number Title Priority Date Filing Date
PH36006A PH24664A (en) 1986-11-03 1987-10-30 Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds and process of preparation thereof
PH39830A PH26261A (en) 1986-11-03 1990-01-02 Endo-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH39830A PH26261A (en) 1986-11-03 1990-01-02 Endo-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one

Country Status (21)

Country Link
EP (1) EP0266730B1 (nl)
JP (2) JP2542225B2 (nl)
KR (1) KR950011737B1 (nl)
CN (1) CN1021654C (nl)
AR (1) AR246264A1 (nl)
AT (1) ATE109779T1 (nl)
AU (1) AU600318B2 (nl)
CA (1) CA1329203C (nl)
DE (2) DE3750359T2 (nl)
DK (1) DK171116B1 (nl)
ES (1) ES2061469T3 (nl)
FI (1) FI87786C (nl)
HU (1) HU197008B (nl)
IE (1) IE63670B1 (nl)
IL (1) IL84309A (nl)
NL (1) NL970043I2 (nl)
NO (2) NO165922C (nl)
NZ (1) NZ222349A (nl)
PH (2) PH24664A (nl)
PT (1) PT86060B (nl)
ZA (1) ZA878096B (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0329903A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
EP0329932B1 (en) * 1988-02-23 1995-10-18 Merrell Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
EP0329905A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility
EP0329904A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety
EP0329902A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis
EP0330788A1 (en) * 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
ZA893008B (en) * 1988-04-29 1989-12-27 Merrell Dow Pharma Process for preparing indole-3-carboxylic acid esters of transhexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
AR016162A1 (es) * 1997-12-17 2001-06-20 Biocryst Pharm Inc Compuestos ciclopentano y ciclopenteno sustituidos que son de utilidad como inhibidores de la neuraminidasa y composicion que los contiene.
CN100390172C (zh) * 2004-09-10 2008-05-28 成都欣捷高新技术开发有限公司 一种甲磺酸多拉司琼晶型及其制备方法
US20070299260A1 (en) * 2004-11-25 2007-12-27 Cilag Ltd. Method for Preparing Hexahydro-8-Hydroxy-2, 6-Methano-2H-Chinolizin-3 (4H) -One Esters
ES2264901B1 (es) 2005-07-06 2007-12-01 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimiento para la obtencion de los mismos.
WO2007003522A1 (en) * 2005-07-06 2007-01-11 Inke, S.A. Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them
US20070203177A1 (en) * 2006-01-05 2007-08-30 Janos Hajko Forms of dolasetron mesylate and processes for their preparation
EP2060557B1 (en) 2007-11-13 2012-06-06 Inke, S.A. Intermediate compounds useful to prepare dolasetron
US8580730B2 (en) 2009-05-20 2013-11-12 (Inserm) Institut National De La Sante Et De La Recherche Medicale Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
WO2017044693A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
CN108976230A (zh) * 2018-06-18 2018-12-11 东莞市联洲知识产权运营管理有限公司 一种基于石墨烯活化制备甲磺酸多拉司琼关键中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
ATE86110T1 (de) * 1984-12-20 1993-03-15 Sandoz Ag Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.

Also Published As

Publication number Publication date
CN1021654C (zh) 1993-07-21
DK171116B1 (da) 1996-06-17
NZ222349A (en) 1990-05-28
KR880006240A (ko) 1988-07-22
JPH0977769A (ja) 1997-03-25
DE19775092I2 (de) 2001-11-22
ES2061469T3 (es) 1994-12-16
HU197008B (en) 1989-02-28
IL84309A (en) 1991-09-16
FI874768A0 (fi) 1987-10-29
NO165922C (no) 1991-05-02
DK572887D0 (da) 1987-11-02
AR246264A1 (es) 1994-07-29
JP2657267B2 (ja) 1997-09-24
PT86060B (pt) 1990-07-31
JP2542225B2 (ja) 1996-10-09
IE63670B1 (en) 1995-05-31
NO1999020I1 (no) 1999-08-26
FI87786C (fi) 1993-02-25
PH26261A (en) 1992-04-01
NL970043I1 (nl) 1998-03-02
EP0266730A1 (en) 1988-05-11
CN87107629A (zh) 1988-06-15
KR950011737B1 (ko) 1995-10-09
JPS63258476A (ja) 1988-10-25
DK572887A (da) 1988-05-04
EP0266730B1 (en) 1994-08-10
NO165922B (no) 1991-01-21
ZA878096B (en) 1988-04-26
PT86060A (en) 1987-12-01
DE3750359T2 (de) 1994-12-08
CA1329203C (en) 1994-05-03
NO874550L (no) 1988-05-04
AU600318B2 (en) 1990-08-09
ATE109779T1 (de) 1994-08-15
IE872955L (en) 1988-05-03
FI874768A (fi) 1988-05-04
NO874550D0 (no) 1987-11-02
HUT45055A (en) 1988-05-30
AU8059687A (en) 1988-05-05
NL970043I2 (nl) 1998-10-01
DE3750359D1 (de) 1994-09-15
FI87786B (fi) 1992-11-13

Similar Documents

Publication Publication Date Title
IL82982A0 (en) Process for the preparation of imidazopyridines and intermediate compounds
PH24664A (en) Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds and process of preparation thereof
EP0274798A3 (en) Process for the preparation of esters
PT84831A (en) Process for the preparation of new pyrazol-3-amines
ZA871657B (en) Process for the preparation of medicament adsorbates
IL83663A0 (en) Preparation of 3-pyrrolidinols
HU896623D0 (en) Process for preparation of fluorinated-diphenyl-ethers
PT82383A (en) Process for the preparation of epipodophyllotoxin and relates compounds
GB8717640D0 (en) Preparation of esters
IL85706A (en) Process for the preparation of nitroethene derivatives and novel intermediate compounds therefor
HU895128D0 (en) Process for preparation of oxazolidine- and imidazolidine-derivatives
EP0255904A3 (en) Process for the preparation of dihydrocyclocitral
GB8727401D0 (en) Preparation of trifluoromethylbenzonitrile
HU896622D0 (en) Process for preparation of 3-benzyl-4-fluor-benzaldehyde
IL82218A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
PT85190A (en) Process for the preparation of mercaptoacylproline
IL82217A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
EP0240741A3 (en) Process for the preparation of inulase
EP0264089A3 (en) Process for the preparation of sulphatobetaines
GB2196961B (en) Preparation of polyfluoroenolates
GB2191773B (en) Process for the preparation of 4-alkoxy-3-pyrrolin-2-ones
IL84778A (en) Preparation of mercaptobenzoates
GB2187737B (en) Preparation of 2,6-dihalo-4-cyanophenol esters
GB8708603D0 (en) Preparation of()-13-norfaranal
NZ222284A (en) Process for the preparation of 1-aminoanthraquinones